Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model (full – 2014)http://download.springer.com/static/...2786b&ext=.pdf

The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full – 2014) http://www.jbc.org/content/early/201...13.536953.long

Involvement of the Cannabinoid CB1 Receptor in Modulation of Dopamine Output in the Prefrontal Cortex Associated with Food Restriction in Rats (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954872/

Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex (full – 2014)http://journal.frontiersin.org/Journ...014.00058/full

Involvement of PAR-4 in Cannabinoid-Dependent Sensitization of Osteosarcoma Cells to TRAIL-Induced Apoptosis (full – 2014)http://www.ijbs.com/v10p0466.htm

Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014)http://onlinelibrary.wiley.com/doi/1...epi.12631/full

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full – 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/

Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24412835

Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24556469

WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24696378

The CB1 Receptor as an Important Mediator of Hedonic Reward Processing (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24718372

Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24867330

WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24867078

Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24866555

Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24897957

Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019

Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25023974

Differential Activation of Intracellular vs Plasmalemmal CB2 Cannabinoid Receptors (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25033246

Effects of opioids and cannabinoids during chronic morphine treatment in rhesus monkeys (abst – 2014)http://www.fasebj.org/content/28/1_S...7-3f56f520a102

Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24259678

The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington's disease may depend on their functional selectivity (abst – 2014)http://www.fasebj.org/content/28/1_S...7-3f56f520a102

The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287

Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25123645

The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25069241